BioRem Valuation
| BRM Stock | CAD 2.42 0.05 2.02% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. BioRem Inc shows a prevailing Real Value of C$2.03 per share. The current price of the firm is C$2.42. Our model approximates the value of BioRem Inc from analyzing the firm fundamentals such as Profit Margin of 0.11 %, return on equity of 0.6, and Current Valuation of 35.48 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BioRem's valuation include:
Price Book 3.9202 | Enterprise Value | Enterprise Value Ebitda 4.6289 | Price Sales 0.9485 | Forward PE 11.2233 |
Overvalued
Today
Please note that BioRem's price fluctuation is very risky at this time. Calculation of the real value of BioRem Inc is based on 3 months time horizon. Increasing BioRem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioRem stock is determined by what a typical buyer is willing to pay for full or partial control of BioRem Inc. Since BioRem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioRem Stock. However, BioRem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.42 | Real 2.03 | Hype 2.38 | Naive 2.45 |
The intrinsic value of BioRem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioRem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioRem Inc helps investors to forecast how BioRem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioRem more accurately as focusing exclusively on BioRem's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use BioRem's intrinsic value based on its ongoing forecasts of BioRem's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against BioRem's closest peers.
BioRem Cash |
|
BioRem Valuation Trend
Analysing the historical paterns of BioRem's enterprise value and its market capitalization is a good way to estimate and gauge the value of BioRem Inc over time and is usually enough for investors to make rational market timing decisions.
BioRem Total Value Analysis
BioRem Inc is currently estimated to have takeover price of 35.48 M with market capitalization of 46.45 M, debt of 4.19 M, and cash on hands of 5.75 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioRem fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.48 M | 46.45 M | 4.19 M | 5.75 M |
BioRem Investor Information
The book value of the company was currently reported as 0.43. The company had not issued any dividends in recent years. BioRem Inc had 1:4 split on the 21st of January 2005. BioRem Inc is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.BioRem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioRem has an asset utilization ratio of 104.52 percent. This indicates that the Company is making C$1.05 for each dollar of assets. An increasing asset utilization means that BioRem Inc is more efficient with each dollar of assets it utilizes for everyday operations.BioRem Ownership Allocation
BioRem holds a total of 15.8 Million outstanding shares. Almost 97.67 percent of BioRem outstanding shares are held by general public with 1.9 (percent) owned by insiders and only 0.44 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioRem Profitability Analysis
The company reported the revenue of 25.17 M. Net Income was 2.18 M with profit before overhead, payroll, taxes, and interest of 6.24 M.About BioRem Valuation
Our relative valuation model uses a comparative analysis of BioRem. We calculate exposure to BioRem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioRem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 8 M | 5.5 M | |
| Pretax Profit Margin | 0.10 | 0.10 | |
| Operating Profit Margin | 0.11 | 0.12 | |
| Net Profit Margin | 0.08 | 0.08 | |
| Gross Profit Margin | 0.32 | 0.34 |
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.